Insider Holders & Insider Ownership - DMK PHARMACEUTICALS Corp (DMK)

List of insiders holdings for DMK PHARMACEUTICALS Corp:
  1. Shares directly owned by the insider.
  2. Shares indirectly owned by the insider.
  3. Total shares owned by the insider (sum of shares directly and indirectly owned).
  4. Total market value if available.
  5. Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Insider Holder NameReport
Date Time		Shares Owned
Directly
Indirectly		Total
Shares Owned		Filing
GREGORY JOHN M
SJ STRATEGIC INVESTMENTS LLC
GREGORY JOAN P
GREGORY JAMES M
PALMER SUSAN
10% Owner		2008-12-17 12:06:180
7,053,993		7,053,993Form 4/A
Aloi Richard L
Director		2009-04-13 18:01:373,593,039
0		3,593,039Form 3
Rahman Ahmed Shayan Fazlur
Eses Holdings (FZE)
10% Owner		2017-09-25 16:30:241,635,315
0		1,635,315Form 13D
TISCH JAMES S
10% Owner		2004-07-29 18:46:05370,378
764,508		1,134,886Form 4
TISCH DANIEL R
10% Owner		2004-07-29 18:46:34370,378
764,508		1,134,886Form 4
TISCH ANDREW H
10% Owner		2004-07-29 18:47:16370,378
764,508		1,134,886Form 4
Versi Ebrahim
CEO		2023-09-19 17:17:248745
907,606		916,351Form 4
Glover Eddie Wabern
CEO of US Compounding, Inc.		2019-02-12 18:44:53741,668
0		741,668Form 5
CARLO DENNIS J PHD
Former President & CEO		2022-05-27 16:07:12535,867
156,592		692,459Form 4
Hopkins Robert O
Chief Financial Officer		2021-02-23 19:07:26277,067
0		277,067Form 4
WILLIAMS RICHARD C
Director		2019-05-28 18:12:47239,918
0		239,918Form 4
Marguglio David J.
SVP and Chief Business Officer		2022-03-22 18:39:00233,906
5884		239,790Form 4
TISCH THOMAS J
10% Owner		2010-02-16 16:59:50206,885
0		206,885Form 13D
Versi Jannine
Director		2023-05-30 18:14:4425,720
179,135		204,855Form 4
Moss Ronald B.
Chief Medical Officer		2022-03-22 18:39:54201,911
0		201,911Form 4
Daniels Karen K.
VP of Operations		2021-02-16 19:48:53163,153
0		163,153Form 5
COHEN SETH
CFO		2023-10-25 17:18:34151,416
0		151,416Form 4
ROTHERMEL ROBERT B
Director		2019-05-28 18:11:42133,500
0		133,500Form 4
Moll Thomas
VP of Research		2018-02-23 17:53:23125,200
0		125,200Form 4
STEIGROD ALAN A
Director		2003-11-10 20:54:49110,556
0		110,556Form 4
DENBY WILLIAM C
Director		2019-05-28 18:13:51108,750
0		108,750Form 4
BOWMAN JACK L
Director		2003-11-10 20:53:02101,806
0		101,806Form 4
Caso Robert J
VP, Finance & CFO		2005-04-07 19:20:54100,000
0		100,000Form 4
WELLS LARRY J
Director		2003-11-13 19:03:0899,114
0		99,114Form 4
SALDARINI RONALD J
Director		2003-11-10 17:29:0479,194
0		79,194Form 4
Dorbin John W. Jr.
General Counsel		2023-11-02 16:50:5270,000
0		70,000Form 4
BIRNDORF HOWARD C
Director		2022-11-16 16:41:2158,824
0		58,824Form 4
Blunt Roshawn A.
Director		2020-02-13 16:21:2550,000
0		50,000Form 4
ADAMS JOHN Q
Director		2009-04-08 12:32:4950,000
0		50,000Form 4
Benedicto David C.
Chief Financial Officer		2022-03-22 18:35:1839,875
0		39,875Form 4
Nova Tina Susan
Director		2013-10-17 17:01:2235,000
0		35,000Form 4
Cohen Kenneth M
Director		2013-10-17 16:59:3835,000
0		35,000Form 4
Johnson Craig A
Director		2013-10-17 16:58:2135,000
0		35,000Form 4
STEINBERG THOMAS M
Director		2005-11-21 21:49:3212,000
0		12,000Form 4
KLAR TOBI B
Director		2005-11-21 21:44:0412,000
0		12,000Form 4
Corner Anne-Marie
Senior Vice President		2005-06-21 17:25:5010,277
0		10,277Form 4
CHANDLER JOHN J
VP, Corporate Development		2005-11-21 21:44:0510000
0		10000Form 4
JUELIS A RICHARD
Vice President		2004-11-05 17:01:526820
0		6820Form 4
Desai Meera J.
Director		2023-05-30 18:15:163138
0		3138Form 4
REED VICKIE S
Director		2022-05-26 16:28:330
0		0Form 3
KARLIN DAVID A
VP, Clinical Research		2004-12-29 14:23:120
0		0Form 4